Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart

被引：0
|
作者：
Ashwell, SG
Gebbie, J
Home, PD
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [21] Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery
    Yeldandi, Renuka R.
    Lurie, Alexander
    Baldwin, David
    DIABETES TECHNOLOGY & THERAPEUTICS, 2006, 8 (06) : 609 - 616
  • [22] Comparison of twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) with once-daily insulin glargine (GLA) in patients with type 2 DM on oral antidiabetic agents
    Raskin, P
    Rojas, P
    Allen, E
    DIABETES, 2004, 53 : A143 - A143
  • [23] A COMPARISON OF TWICE-DAILY BIPHASIC INSULIN ASPART 70/30 AND ONCE-DAILY INSULIN GLARGINE IN PERSONS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON BASAL INSULIN AND ORAL THERAPY: A RANDOMIZED, OPEN-LABEL STUDY
    Ligthelm, Robert J.
    Gylvin, Titus
    DeLuzio, Tony
    Raskin, Philip
    ENDOCRINE PRACTICE, 2011, 17 (01) : 41 - 50
  • [24] Therapeutic effectiveness of two insulin regimens for insulin naive patients with type 2 diabetes mellitus: Once-daily basal insulin or twice-daily premixed insulin?
    Sun, Peter
    Wang, Ruoping
    Jacober, Scott J.
    DIABETES, 2006, 55 : A101 - A101
  • [25] Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
    Eledrisi, Mohsen
    Suleiman, Noor Nabeel
    Salameh, Obada
    Hamad, Mohammad Khair
    Rabadi, Omar
    Mohamed, Ahmed
    Al Adawi, Rana
    Salam, Abdul
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 15 : 35 - 36
  • [26] Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)
    Roussel, Ronan
    d'Emden, Michael C.
    Fisher, Miles
    Javier Ampudia-Blasco, F.
    Stella, Peter
    Bizet, Florence
    Cali, Anna M. G.
    Wysham, Carol H.
    DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 448 - 452
  • [27] Effects of exenatide compared with twice-daily biphasic insulin aspart in patients with type 2 diabetes using metformin and a sulphonylurea
    Nauck, M. A.
    Duran, S.
    Kim, D.
    Johns, D.
    Festa, A.
    Trautmann, M.
    DIABETOLOGIA, 2006, 49 : 3 - 3
  • [28] Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
    Tosaka, Yuka
    Kanazawa, Akio
    Ikeda, Fuki
    Iida, Mayu
    Sato, Junko
    Matsumoto, Kazuhisa
    Uchida, Toyoyoshi
    Tamura, Yoshifumi
    Ogihara, Takeshi
    Mita, Tomoya
    Shimizu, Tomoaki
    Goto, Hiromasa
    Ohmura, Chie
    Fujitani, Yoshio
    Watada, Hirotaka
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [29] Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study
    Galasso, S.
    Facchinetti, A.
    Bonora, B. M.
    Mariano, V.
    Boscari, F.
    Cipponeri, E.
    Maran, A.
    Avogaro, A.
    Fadini, G. P.
    Bruttomesso, D.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (12) : 1112 - 1119
  • [30] Starting insulin for Type 2 diabetes with insulin glargine added to oral agents versus twice-daily premixed insulin alone
    Janka, HU
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETOLOGIA, 2004, 47 : A269 - A270
12345